This vector was quite efficient against MC38 tumors in a human PD-1 (hPD-1) knock-in mouse tumor model, having a similar effect to the combination of control virus and systemic anti-PD-1 mAb administration. This evidence concerns the gene PDCD1 and neoplasm.